WHO ICTRP trial
Postmarketing clinical study on AO-128
JPRN-jRCT1080220971 · Japan Primary Registries Network (JPRN)
Key facts
| Trial ID | JPRN-jRCT1080220971 |
|---|---|
| Public title | Postmarketing clinical study on AO-128 |
| Scientific title | Postmarketing clinical study on AO-128 |
| Primary sponsor | Takeda Pharmaceutical Company Limited |
| Registry | Japan Primary Registries Network (JPRN) |
| Study type | Interventional |
| Phase | 4 |
| Conditions | Impaired glucose tolerance |
| Interventions | investigational material(s) Generic name etc : AO-128 (BASEN Tablets 0.2) INN of investigational material : Therapeutic category code : 396 Antidiabetic agents Dosage and Administration for Investigational material : Oral administration |
| Registration date | Jan 21, 2010 |
| Target size | 197 |
| Secondary IDs | JapicCTI-101004 |
| Registry page | jrct.niph.go.jp |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: